Founded: Started in 1997 and pioneered Venture Group model in 2019. 

300+ Active Members: Investors Include current and retired executives, serial entrepreneurs, scientists, engineers, and venture partners. 

Venture Group Model: A novel structure that blends collective decision-making with targeted expertise, allowing both fund-level and individual member investments. 

Investment Focus: Over $10M+ average invested annually (2019–2025) across Technology (AI, software, hardware, climatetech, mobile) and Life Sciences (biotech, healthtech, medical devices, genomics, diagnostics). 

Portfolio Impact: Over 110 funding rounds since 2019 across diverse verticals, ranging from pre-seed to pre-IPO stages. 

Success Stories: 85% of portfolio companies since 2019 are active and growing, landmark achievements include the 2023 $1B acquisition of DTx Pharma by Novartis. 

National Reach: While rooted in Southern California, our investments and members span nationwide.